Nurses' Experiences of Pain Management for Patients With Diagnosed Mental Health Conditions: A Systematic Review.

J Adv NursApr 29, 2026 (epub)
Clinical ResearchPsychiatry

Aaron Lapuz Alejandro, Yvonne Middlewick, Seng Giap Marcus Ang et al.

✦ AI-curated · Sources linked

In 30 seconds

This mixed-methods systematic review synthesised evidence on nurses’ pain assessment and management for patients with diagnosed mental health conditions. Searches identified 1,318 eligible studies, of which 12 met inclusion criteria. Findings described inconsistent assessment, reliance on visible signs, uncertainty about trusting patients’ reports, diagnostic overshadowing, and the influence of organisational constraints and support. The review concludes that stigma can contribute to pain being under-assessed and inadequately treated, and identifies education, institutional support, and validated assessment tools as ways to strengthen nursing practice.

Key findings

  • Twelve studies met inclusion criteria from 1,318 eligible studies identified.
  • Six themes included inconsistent assessment, reliance on visible signs, trust in patient reports, diagnostic overshadowing, and organisational influences.
  • Barriers included inconsistent use of assessment tools, limited nursing knowledge and confidence, power imbalances, and organisational constraints.
  • Studies were predominantly conducted in high-income countries and frequently neglected nonresponse bias.

Why it matters

Pain may be under-assessed or inadequately treated when mental health diagnoses shape how clinicians interpret symptoms and patient reports. The review highlights that assessment practices are influenced not only by individual nursing knowledge and judgement but also by stigma, education, resources, and institutional policies. Recognising these influences can inform efforts to support more consistent, person-centred pain care.

What to keep in mind

The evidence base comprised 12 studies, was predominantly from high-income countries, and frequently neglected nonresponse bias, potentially limiting generalisability.

Source

Published in J Adv Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.